SCHEMBL29798283

SCHEMBL29798283

O=C(CSc1nnnn1-c1ccccc1C(=O)O)NCc1cccc(C2CC2)c1

nearest known ligand 0.54

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 13/20 0.53
▸ L3MBTL1 Q9Y468 1/20 0.52
▸ MEN1 O00255 2/20 0.52
▸ KMT2A Q03164 2/20 0.52
▸ MAPK1 P28482 1/20 0.48
▸ TSHR P16473 3/20 0.47
▸ LMNA P02545 1/20 0.47
▸ RECQL P46063 1/20 0.47
▸ HPGD P15428 2/20 0.46
▸ HTT P42858 1/20 0.46
▸ POLB P06746 1/20 0.46
▸ CYP1A2 P05177 1/20 0.45
▸ CYP3A4 P08684 1/20 0.45
▸ CYP2D6 P10635 1/20 0.45
▸ CYP2C19 P33261 1/20 0.45
▸ NPSR1 Q6W5P4 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21952023 0.85 ALDH1A1 (0.58) ALDH1A1L3MBTL1MEN1KMT2AMAPK1
SCHEMBL31396267 0.85 ALDH1A1 (0.58) ALDH1A1L3MBTL1MEN1KMT2AMAPK1
SCHEMBL31396264 0.83 ALDH1A1 (0.55) ALDH1A1L3MBTL1MEN1KMT2AMAPK1
SCHEMBL21952059 0.83 ALDH1A1 (0.55) ALDH1A1L3MBTL1MEN1KMT2AMAPK1
SCHEMBL29798225 0.82 ALDH1A1 (0.53) ALDH1A1L3MBTL1MEN1KMT2AMAPK1
SCHEMBL29798314 0.81 ALDH1A1 (0.57) ALDH1A1MEN1KMT2AMAPK1TSHR
SCHEMBL29798321 0.78 CPB1 (0.47) ALDH1A1L3MBTL1MEN1KMT2AMAPK1
SCHEMBL21952094 0.76 ALDH1A1 (0.60) ALDH1A1L3MBTL1MEN1KMT2AMAPK1
SCHEMBL31396379 0.76 ALDH1A1 (0.60) ALDH1A1L3MBTL1MEN1KMT2AMAPK1
SCHEMBL29798204 0.75 TSHR (0.61) ALDH1A1MEN1KMT2AMAPK1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4149461-A1 UBIQUITIN-LIGASE INHIBITORS FOR THE TREATMENT OF CANCER Fundación Profesor Novoa Santos (ES) 2023-03-22 — — EP disclosed
WO-2021229035-A9 UBIQUITIN-LIGASE INHIBITORS FOR THE TREATMENT OF CANCER FUNDACIÓN PROFESOR NOVOA SANTOS (ES) 2022-09-09 — — WO disclosed
Send feedback